Samuel Calabrese

Cleveland Clinic

Papers

2

Total Citations

28

H-Index

2

About

Samuel Calabrese is a leading voice in the advancement of automated intravenous (IV) medication compounding, a critical area where precision and safety are paramount. His research focuses on the integration of robotic systems into pharmacy practice, specifically addressing the challenges and best practices of transitioning from manual to robotic compounding. Calabrese’s major contribution lies in establishing the foundational guidelines for this emerging field. His most cited work, "Robotic i.v. medication compounding: Recommendations from the international community of APOTEC Achemo users" (2016, 25 citations), provides essential, consensus-driven recommendations for implementing robotics to enhance patient safety and workflow efficiency. He further solidified his role as a key thought leader by organizing and publishing the proceedings of the "Cleveland Clinic International IV Robotics Summit" (2021, 3 citations), which convened global experts to define the current and desired future state of the technology. Through this pioneering work, Calabrese is not just observing a shift in pharmacy practice—he is actively shaping the standards for a safer, more automated future in medication preparation.

Research Focus

Key Achievements

2
H-Index
2
Papers
28
Total Citations
14
Avg Citations/Paper
🏆 Most Cited Paper
Robotic i.v. medication compounding: Recommendations from the international community of APOTECAchemo users
25 citations · 2016
📈 Most Prolific Year: 2016 (1 Papers)
🤝 Key Collaborators: 27
🏛 Institutions: Cleveland Clinic

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago